Forbion co-leads $245 million Series A financing of Aiolos

Oct 24, 2023  · SAN FRANCISCO AND LONDON – October 24, 2023 - Forbion, a leading European life sciences venture capital firm, today announces that it has co-led a $245 million …


Install CouponFollow Chrome Extension   CouponFollow Extension

$245
OFF

Forbion Co-leads $245 Million Series A Financing Of Aiolos

2 days from now

Oct 24, 2023  · SAN FRANCISCO AND LONDON – October 24, 2023 - Forbion, a leading European life sciences venture capital firm, today announces that it has co-led a $245 million …

forbion.com

$245
OFF

Aiolos Bio Launches With $245 Million Series A Investment To …

2 days from now

Oct 24, 2023  · Aiolos launches with an oversubscribed $245 million Series A investment co-led by Atlas Venture, Bain Capital Life Sciences, Forbion, and Sofinnova Investments with additional …

businesswire.com

$245
OFF

Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) To Be Acquired …

2 days from now

Jan 9, 2024  · This follows a $245 million Series A financing in Aiolos in October 2023, co-led by Forbion, alongside Atlas Venture, Bain Capital Life Sciences, and Sofinnova Investments with …

forbion.com

$245
OFF

Bain Capital

2 days from now

Oct 24, 2023  · Aiolos launches with an oversubscribed $245 million Series A investment co-led by Atlas Venture, Bain Capital Life Sciences, Forbion, and Sofinnova Investments with additional …

baincapital.com

$245
OFF

Aiolos Bio Raises $245M On Prospect Of Better Asthma Drug

2 days from now

Oct 24, 2023  · A new biotechnology company has raised $245 million in a Series A financing round on the promise of an asthma drug that only needs to be taken twice a year. Aiolos Bio is …

biopharmadive.com

$245
OFF

Aiolos $245m Series A Heads Latest Crop Of Biotech Rounds

2 days from now

3 days ago  · A new US biotech, Aiolos Bio, has drawn in an impressive $245 million in Series A financing that will help it complete clinical testing of lead drug AIO-001 for moderate-to-severe …

pharmaphorum.com

$245
OFF

Forbion Co-leads $245 Million Series A Financing Of Aiolos Bio

2 days from now

• Series A financing round co-led by Forbion, Atlas Venture, Bain Capital Life Sciences, and Sofinnova Investments with additional investment from RA Capital Management. • Aiolos Bio …

forbion.com

$245
OFF

Aiolos Bio Debuts With $245 Million Financing | The Pharmaletter

2 days from now

Oct 24, 2023  · San Francisco, USA-based biotech start-up Aiolos Bio has today emerged out of stealth, backed by an oversubscribed $245 million Series A investment.

thepharmaletter.com

$245
OFF

Aiolos Bio Raises $245M In Series A Funding - FinSMEs

2 days from now

Oct 25, 2023  · Aiolos Bio, a San Francisco, CA-based clinical-stage biopharmaceutical company, raised $245M in Series A funding. The round was led by Atlas Venture, Bain Capital Life …

finsmes.com

$245
OFF

Aiolos Bio Launches With $245M Series A - Jacobsmgt.com

2 days from now

San Francisco & London, October 24, 2023 (Business Wire) -- Aiolos Bio, Inc. has launched as a clinical-stage biopharmaceutical company that aims to address the unmet respiratory and …

jacobsmgt.com

€10
OFF

Aiolos Bio, Inc.. (10/24/23). "Press Release: Aiolos Bio Launches …

2 days from now

LoQus23 Therapeutics Closes £35m Series A Led by Forbion; Bruker Acquires Dynamic Biosensors for Undisclosed Sum; Sequentia Biotech Raises €10m Series A Led by Seventure; …

life-sciences-europe.com

$245
OFF

Aiolos Bio Launches With $245 Million Series A Investment To

2 days from now

Oct 24, 2023  · SAN FRANCISCO & LONDON--(BUSINESS WIRE)-- Aiolos Bio, Inc. (“Aiolos” or “the Company”) today announced its launch as a clinical-stage biopharmaceutical company …

biospace.com

$245
OFF

Forbion On LinkedIn: Forbion Co-leads $245 Million Series A …

2 days from now

Aiolos Bio has raised $245 million in a Series A financing round co-led by Forbion, Atlas Venture, Bain Capital Life Sciences Fund LP, and Sofinnova Investments with additional investment …

linkedin.com

$245
OFF

More Documents For Forbion (Group) - Life-sciences-europe.com

2 days from now

This follows a $245 million Series A financing in Aiolos in October 2023, co-led by Forbion, alongside Atlas Venture, Bain Capital Life Sciences, and Sofinnova Investments with …

life-sciences-europe.com

$1
OFF

GSK, Moving Fast To Buy Aiolos, Pays $1B To Challenge Amgen ...

2 days from now

Jan 9, 2024  · Aiolos broke cover in late October, launching with a $245 million series A round co-led by Atlas Venture, Bain Capital Life Sciences, Forbion and Sofinnova Investments.

fiercebiotech.com

$190
OFF

Forbion Co-leads $190 Million Financing Of Marea Therapeutics

2 days from now

Jun 18, 2024  · • As part of the financing, Antoine Boulanger, PhD, will join the Board of Directors. Naarden, The Netherlands – June 18, 2024 – Marea Therapeutics, a clinical-stage …

forbion.com

FAQs about Forbion co-leads $245 million Series A financing of Aiolos Coupon?

How much money did Aiolos bio raise?

On Tuesday, San Francisco- and London-based Aiolos Bio, a newly launched startup with an asthma drug in clinical trials, announced that it raised $245 million in Series A funding. Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners and Sofinnova Investments led the round, with additional investment from RA Capital Management. ...

Why did Aiolos bio invest $245 million in series a funds?

Aiolos Bio used $245 million in series A funds in part to pay for a phase 2-ready asset being developed as a treatment for severe asthma. ...

Is Aiolos a good investment for a biotech?

While investors have shown more appetite for biotechs in recent months, the Aiolos financing stands out. The total funding tops any venture capital round for a biotech during the first quarter and comes close to the top five of the second quarter, according to the pharmaceutical industry information company Evaluate. ...

Does Aiolos bio attract seismic capital in 2023?

Aiolos Bio's lead asset has already been tested on more than 100 people in China and New Zealand. (Olivier Le Moal/Getty Images) A consistent theme of 2023 has been that advanced assets attract seismic capital and a newly launched biotech adds more proof to the pile. ...

Did Aiolos spend $245 million on licensing a biomedical asset?

The $245 million has been spent in part on licensing the asset, the financial details of which Aiolos leadership declined to disclose in an interview with Fierce Biotech, beyond saying that it involved upfront and milestone payments. Hengrui did not respond to a request for additional details. ...

Which biotech companies have raised $245 million in Series A funding?

The Series A funding round ranks among the largest in the biotech industry this year, with investors including Atlas, Bain and Forbion backing the startup. A new biotechnology company has raised $245 million in a Series A financing round on the promise of an asthma drug that only needs to be taken twice a year. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension